Skip to content

ARGOS THERAPEUTICS INC

CIK 0001105533

← back to feed
Revenue (TTM)
$375.21K
+3,023.4% YoY Q3 Nov 2018
Net Income (TTM)
−$19.66M
+68.8% YoY Q3 Nov 2018
EPS Diluted (TTM)
—
Q3 Nov 2018
Gross Margin
—
Q3 Nov 2018
Operating Margin
-5,763.3%
Q3 Nov 2018
Net Margin
-5,238.9%
Q3 Nov 2018
Free Cash Flow (TTM)
−$45.79M
Q3 Nov 2018
Cash
$7.94M
Q3 Nov 2018
Total Debt
$11.98M
Q3 Nov 2018
Shares Outstanding
10.59M sh
Q3 Nov 2018

Revenue & Net Income

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings